Trelice
Trelice accelerates study startup with a protocol authoring platform and automatic downstream document generation and formatting, all led by regulatory requirements.
Problem & solution
Clinical trials lose months before the first patient enrolls because protocols are managed in Word and SharePoint, with limited ownership, oversight, or regulatory guidance. Errors and conflicts spread across every document built from the protocol. Trelice makes the protocol the single source of truth: teams write and review it in one structured workspace, generate study documents from the same data, and automatically update affected content when the protocol changes.
Primary customers & users
Trelice is purchased by pharma and biotech sponsors, CROs, medical-writing consultancies, and research sites. Decision-makers lead Clinical Operations, Medical Writing, Regulatory Affairs, or site operations. Users include Clinical operations, clinical scientists, writers, study managers, reviewers, investigators, and coordinators.
Differentiation
The alternatives are either AI MS Word plugins that no one needs or cumbersome systems that are very difficult to use and 90% of the features are not relevant. Trelice has the features the industry needs and wants, such as audit trail, embedded project management and automated docs. Based on vendor assessment notes from a large pediatric hospital.
Current traction
2 bio tech companies (one in advanced evaluation, one in procurement), major pediatric hospital in evaluation, medical writers group showing interest, CRO in evaluation.
How Summit participants can help
First, Introduction to potential customers - Pharma companies, CROs and Sites of clinical research. Second, Funding opportunities, as the deck specifies.